318
Participants
Start Date
June 30, 2016
Primary Completion Date
August 31, 2020
Study Completion Date
October 31, 2020
DTG +DRV/r
NRTI-sparing regimen: Once daily integrase inhibitor (INSTI) + darunavir/ritonavir (DRV/r)
SOC
Standard of care (continuing triple anti-retroviral therapy including 2 NRTIs + boosted PI/NNRTI)
Hospital Garrahan, Buenos Aires
Centre Hospitalier Andrée Rosemon, Cannes
CHU Hôtel Dieu - Nantes, Nantes
Hospital General Mexico, Mexico City
Hospital de Dona Estefânia - CHLC, Lisbon
Centro Materno-Infantil de Norte, Porto
FAM-CRU, Cape Town
PHRU, Soweto
Hospital San Joan de Deu, Barcelona
Hospital Clínico San Carlos, Madrid
Hospital General Gregorio Marañón, Madrid
Hospital La Paz, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario de Getafe, Madrid
Inselpital Bern, Bern
Kantonsspital St Gallen, Sankt Gallen
Kinderspital Zurich, Zurich
Prapokklao Hospital, Chanthaburi
Nakornping Hospital, Chiang Mai
Chiangrai Prachanukroh Hospital, Chiang Rai
Kalasin hospital, Kalasin
Khonkaen hospital, Khon Kaen
Phayao hospital, Phayao
Baylor, Kampala
JCRC, Mbarara
Kiev, Kiev
Kryvyi Rih, Kryvyi Rih
Birmingham Heartlands Hospital, Birmingham
Bristol Hospital, Bristol
Evelina Children Hospital, St Thomas's Hospital, London
King's College Hospital, London
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
MRC CTU at UCL
UNKNOWN
PHPT
UNKNOWN
PENTA Foundation
NETWORK